Abundant Ventures
We provide financing solutions specific to your immediate and future needs. Our approach targets opportunities that will maximize growth and profitability while minimizing risk and asset loss. Our team of professionals focus on capitalizing proven business practices to facilitate growth. Our value to you incorporates business solutions that can integrate with your existing creditors and customers. Our customers include: Manufacturing, Technology, Start up, Service, Construction, Distribution, Integrators, Real Estate, and Temporary employment companies. Financing Solutions: Asset Based Lending -Real Estate-Equipment-Inventory Accounts Receivable Financing - Factoring Commercial Lending - Real Estate- Inventory- Purchase Order Financing Private Equity Funding - Hedge Fund Participation Venture Capital Funding Our Customer needs include: Start up Commercial Credit Lines Increase working capital for expanding market share Seasonal business funding Solutions for Credit Risk Customers Leveraged mergers and acquisitions funding Turnaround- bankruptcy restructuring assistance Additional Solutions we can provide - Abundant Ventures LLC: Business Plan Development and enhancement Strategic Partnerships & Licensing implementations Mergers and Acquisitions funding and assistance Real Estate Planning and Development Management Buyout Funding Solutions
Healthfinch's Practice Automation Platform, Charlie, leverages EMR data to automate, delegate and simplify routine, repeatable tasks, like prescription refill requests, visit planning, diagnostics results management, and more. Its Charlie Practice Automation Platform integrates seamlessly with Allscripts, Epic, and athena EMRs to automate the prescription refill request workflow, assist in pre-visit planning, and identify care gaps. The company was founded in 2011 and is headquartered in Madison, Wisconsin.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.